Order Article Reprints

Alyami MH, Musallam AA, Ibrahim TM, Mahdy MA, Elnahas HM, Aldeeb RA. The Exploitation of pH-Responsive Eudragit-Coated Mesoporous Silica Nanostructures in the Repurposing of Terbinafine Hydrochloride for Targeted Colon Cancer Inhibition: Design Optimization, In Vitro Characterization, and Cytotoxicity Assessment. Pharmaceutics. 2023; 15(12):2677. https://doi.org/10.3390/pharmaceutics15122677

Alyami, Mohammad H., Abeer A. Musallam, Tarek M. Ibrahim, Mahmoud A. Mahdy, Hanan M. Elnahas, and Reem A. Aldeeb. 2023. "The Exploitation of pH-Responsive Eudragit-Coated Mesoporous Silica Nanostructures in the Repurposing of Terbinafine Hydrochloride for Targeted Colon Cancer Inhibition: Design Optimization, In Vitro Characterization, and Cytotoxicity Assessment" Pharmaceutics 15, no. 12: 2677. https://doi.org/10.3390/pharmaceutics15122677

Alyami, M. H., Musallam, A. A., Ibrahim, T. M., Mahdy, M. A., Elnahas, H. M., & Aldeeb, R. A. (2023). The Exploitation of pH-Responsive Eudragit-Coated Mesoporous Silica Nanostructures in the Repurposing of Terbinafine Hydrochloride for Targeted Colon Cancer Inhibition: Design Optimization, In Vitro Characterization, and Cytotoxicity Assessment. Pharmaceutics, 15(12), 2677. https://doi.org/10.3390/pharmaceutics15122677